China Pharmaceutical (600056.SH): Uradil hydrochloride injection obtained drug registration certificate

Zhitongcaijing · 3d ago

Zhitong Finance App News, China Pharmaceutical (600056.SH) issued an announcement. Recently, Tianfang Pharmaceutical Co., Ltd. (“Tianfang Pharmaceutical”), a wholly-owned subsidiary of the company, received two copies of uradyl hydrochloride injections (hereinafter referred to as “this drug”) and “Drug Registration Certificates” approved and issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”). This time, Tianfang Pharmaceutical obtained a drug registration certificate for uradyl hydrochloride injection, which is conducive to enriching the company's cardiovascular drug product line, and has accumulated valuable experience for the company's subsequent generic drug development.